VCEL
Vericel Corporation
A biopharmaceutical company that grows patients' own cells into treatments for sports injuries and severe burns. Its flagship product, MACI, repairs torn knee cartilage, while Epicel grows a patient's skin cells into a permanent graft for large burns. Founded in 1989 as Aastrom Biosciences, it became Vericel in 2014 after buying Sanofi's cell-therapy business. The name plays on the word "cell," and thousands of burn patients have been treated with Epicel.
CUSIP: 92346J108HealthcareUS1 holder
Total Value
$1.15M
Total Shares
25.9K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
